Physician profile
Robert Burk
NPI 1174630644
$9,137.24
in general payments reported to CMS, 2019-2025
15 companies · $1,853 in 2025
The $1,853 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $1,081 · 2021: $2,114 · 2022: $1,219 · 2023: $1,147 · 2024: $1,050 · 2025: $1,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,050.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,411.38 | 2019-2022 | |
| Abbvie INC. | $3,082.37 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Sientra, INC. | $1,052.11 | 2020-2022 | |
| Mentor Worldwide LLC | $474.84 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Solta Medical, A Division of Bausch Health US, LLC | $275.48 | 2022-2025 | Clear+Brilliant |
| Tela Bio, INC. | $237.00 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Motiva USA, LLC | $160.78 | 2024-2025 | |
| Galderma Laboratories, L.P. | $101.24 | 2021-2025 | |
| Innovation Technologies INC | $101.01 | 2022 | |
| Davol INC. | $89.91 | 2021-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $61.52 | 2022-2023 | Lens 4k |
| Pacira Pharmaceuticals Incorporated | $35.84 | 2023 | Iovera, Exparel, Zilretta |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $19.58 | 2019 | |
| Apyx Medical Corporation | $17.83 | 2020 | |
| Pfizer INC. | $16.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.